Global and Specific Translational Control by Rapamycin in T Cells Uncovered by Microarrays and Proteomics
Open Access
- 1 June 2002
- journal article
- Published by Elsevier BV
- Vol. 277 (25), 22175-22184
- https://doi.org/10.1074/jbc.m202014200
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The Proteasome Regulates Receptor-mediated Endocytosis of Interleukin-2Journal of Biological Chemistry, 2001
- Central Role for G Protein-Coupled Phosphoinositide 3-Kinase γ in InflammationScience, 2000
- Roles of PLC-β2 and -β3 and PI3Kγ in Chemoattractant-Mediated Signal TransductionScience, 2000
- New treatment possibilities in rheumatoid arthritis: REVIEWScandinavian Journal of Rheumatology, 2000
- Rapamycin inhibits proteasome activator expression and proteasome activityEuropean Journal of Immunology, 1997
- BIN1 is a novel MYC–interacting protein with features of a tumour suppressorNature Genetics, 1996
- FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cellsEuropean Journal of Immunology, 1995
- Effects of Orally Administered Rapamycin in Animal Models of Arthritis and Other Autoimmune DiseasesAnnals of the New York Academy of Sciences, 1993
- Rapamycin: FK506's fraternal twin or distant cousin?Immunology Today, 1991
- A two‐dimensional electrophoresis‐related laboratory information processing system: Spot matchingElectrophoresis, 1991